Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of LncRNA H19 in The Regulation of IGF-1R Expression: A Possible Association Between Type 2 Diabetes and Hepatocellular Carcinoma

NCT04767750 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT04767750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04767750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of LncRNA H19 in The Regulation of IGF-1R Expression: A Possible Association Between Type 2 Diabetes and Hepatocellular Carcinoma
Lead sponsor
Mansoura University
Phase
Observational
Overall status
Completed
Start date
January 1, 2020
Completion date
April 4, 2022
Enrollment
101 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, hepatocellular carcinoma, type 2 diabetes